Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE

Holdings detail for RAPT

Show aggregate RAPT holdings

News associated with RAPT

Analysts Set Rapt Therapeutics (NASDAQ:RAPT) PT at $21.57

Rapt Therapeutics (NASDAQ:RAPT – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating on the […] - 2025-08-20 03:10:52

Two Sigma Investments LP Sells 339,957 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT)

Two Sigma Investments LP lowered its holdings in shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 65.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 180,465 shares of the company’s stock after selling 339,957 shares during the period. […] - 2025-06-12 04:28:52

Millennium Management LLC Sells 222,261 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT)

Millennium Management LLC cut its stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 23.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 737,704 shares of the company’s stock after selling 222,261 shares during the period. Millennium Management LLC’s holdings in RAPT Therapeutics were worth $1,166,000 as of its most recent filing […] - 2025-06-05 04:42:43

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Sold by Two Sigma Advisers LP

Two Sigma Advisers LP trimmed its stake in shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 28.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 503,700 shares of the company’s stock after selling 201,300 shares during the quarter. Two Sigma Advisers […] - 2025-06-03 04:56:52

Geode Capital Management LLC Raises Position in RAPT Therapeutics, Inc. (NASDAQ:RAPT)

Geode Capital Management LLC lifted its stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 4.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 716,937 shares of the company’s stock after purchasing an additional 33,758 shares during the period. Geode Capital […] - 2025-05-01 04:30:59

Analysts Set RAPT Therapeutics, Inc. (NASDAQ:RAPT) PT at $5.29

RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have given a buy recommendation to the […] - 2025-02-26 04:22:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) RAPT holdings

Date	Number of RAPT Shares Held	Base Market Value of RAPT Shares	Local Market Value of RAPT Shares	Change in RAPT Shares Held	Change in RAPT Base Value	Current Price per RAPT Share Held	Previous Price per RAPT Share Held
2025-12-24 (Wednesday)	18,441	USD 660,925	USD 660,925	0	USD 8,114	USD 35.84	USD 35.4
2025-12-23 (Tuesday)	18,441	USD 652,811	USD 652,811	-516	USD -38,551	USD 35.4	USD 36.47
2025-12-22 (Monday)	18,957	USD 691,362	USD 691,362	0	USD 50,426	USD 36.47	USD 33.81
2025-12-19 (Friday)	18,957	USD 640,936	USD 640,936

Share Trades of RAPT by Blackrock for IE00BDZVHG35

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-23	SELL	-516	36.725	35.100	35.262	USD -18,195	2.65 Loss of -16,829 on sale
2024-11-18	SELL	-870	8.800	9.760	9.664	USD -8,408	2.15 Loss of -6,534 on sale
2024-11-08	SELL	-58	23.120	25.120	24.920	USD -1,445	2.13 Loss of -1,322 on sale
2024-10-21	SELL	-58	13.160	14.560	14.420	USD -836	0.00 Loss of -836 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RAPT

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy